Phase Ib Study of BKM120 Combined With Abiraterone Acetate for Docetaxel-pretreated, Castrate-resistant, Metastatic Prostate Cancer
Phase of Trial: Phase I
Latest Information Update: 07 Feb 2019
At a glance
- Drugs Buparlisib (Primary) ; Abiraterone acetate; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 25 Jan 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Sep 2017.
- 25 Jan 2016 Status changed from active, no longer recruiting to discontinued, as reported by ClinicalTrials.gov.